Orthofix Medical Inc. provided net sales guidance for the year ended December 31, 2022. For the year, company expects net sales to be $475.0 million to $490.0 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.25 USD | +0.23% | +4.41% | -1.63% |
06-24 | Orthofix Medical Names Michael Finegan as Board Chair | MT |
06-24 | Orthofix Medical Inc. Appoints Michael Finegan as Chair of Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.63% | 496M | |
-5.05% | 182B | |
-4.32% | 103B | |
-5.43% | 66.94B | |
+10.78% | 46.73B | |
-7.66% | 45.14B | |
+5.82% | 41.57B | |
+16.82% | 30.48B | |
+14.00% | 24.26B | |
-6.05% | 23.58B |
- Stock Market
- Equities
- OFIX Stock
- News Orthofix Medical Inc.
- Orthofix Medical Inc. Provides Net Sales Guidance for the Year Ended December 31, 2022